Search Results

There are 2910 results for: content related to: Fibrates as adjuvant therapy for chronic cholestatic liver disease: Its time has come

  1. Pharmacological interventions for primary biliary cholangitis

    Intervention Review

    The Cochrane Library

    Francesca Saffioti, Kurinchi Selvan Gurusamy, Leonardo Henry Eusebi, Emmanuel Tsochatzis, Brian R Davidson and Douglas Thorburn

    Published Online : 28 MAR 2017, DOI: 10.1002/14651858.CD011648.pub2

  2. You have free access to this content
    Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid

    Hepatology

    Volume 57, Issue 5, May 2013, Pages: 1931–1941, Akira Honda, Tadashi Ikegami, Makoto Nakamuta, Teruo Miyazaki, Junichi Iwamoto, Takeshi Hirayama, Yoshifumi Saito, Hajime Takikawa, Michio Imawari and Yasushi Matsuzaki

    Version of Record online : 5 APR 2013, DOI: 10.1002/hep.26018

  3. Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid

    Journal of Gastroenterology and Hepatology

    Volume 26, Issue 9, September 2011, Pages: 1395–1401, Yasuto Takeuchi, Fusao Ikeda, Shin-ichi Fujioka, Toshiyuki Takaki, Toshiya Osawa, Tetsuya Yasunaka, Yasuhiro Miyake, Akinobu Takaki, Yoshiaki Iwasaki, Haruhiko Kobashi, Kazuhide Yamamoto and Tatsuya Itoshima

    Version of Record online : 25 AUG 2011, DOI: 10.1111/j.1440-1746.2011.06737.x

  4. You have free access to this content
    Poster Session 1: Pathogenesis and Mechanisms; PBC/PSC and Other Cholestatic Disease

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 498A–530A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28214

  5. Old and new treatments for primary biliary cholangitis

    Liver International

    Volume 37, Issue 4, April 2017, Pages: 490–499, David Chascsa, Elizabeth J. Carey and Keith D. Lindor

    Version of Record online : 30 MAR 2017, DOI: 10.1111/liv.13294

  6. You have free access to this content
    Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid–induced cholestasis in rat liver

    Hepatology

    Volume 52, Issue 5, November 2010, Pages: 1758–1768, Gerald U. Denk, Silvia Maitz, Ralf Wimmer, Christian Rust, Pietro Invernizzi, Sacha Ferdinandusse, Wim Kulik, Andrea Fuchsbichler, Peter Fickert, Michael Trauner, Alan F. Hofmann and Ulrich Beuers

    Version of Record online : 29 OCT 2010, DOI: 10.1002/hep.23911

  7. You have free access to this content
    Ursodeoxycholic acid — adverse effects and drug interactions

    Alimentary Pharmacology & Therapeutics

    Volume 18, Issue 10, November 2003, Pages: 963–972, W. Hempfling, K. Dilger and U. Beuers

    Version of Record online : 14 NOV 2003, DOI: 10.1046/j.1365-2036.2003.01792.x

  8. You have full text access to this OnlineOpen article
    Update on pharmacotherapies for cholestatic liver disease

    Hepatology Communications

    Volume 1, Issue 1, February 2017, Pages: 7–17, Ahmad H. Ali, James H. Tabibian and Keith D. Lindor

    Version of Record online : 21 DEC 2016, DOI: 10.1002/hep4.1013

  9. You have free access to this content
    Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 8, August 1999, Pages: 979–995, Trauner and Graziadei

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00596.x

  10. You have free access to this content
    Guidelines for the management of primary biliary cirrhosis

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 71–90, Working Subgroup (English version) for Clinical Practice Guidelines for Primary Biliary Cirrhosis

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12270

  11. You have full text access to this OnlineOpen article
    Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 11-12, December 2013, Pages: 1354–1364, V. Papastergiou, E. A. Tsochatzis, M. Rodriquez-Peralvarez, E. Thalassinos, G. Pieri, P. Manousou, G. Germani, C. Rigamonti, V. Arvaniti, S. Karatapanis and A. K. Burroughs

    Version of Record online : 4 OCT 2013, DOI: 10.1111/apt.12522

  12. You have free access to this content
    Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 2, January 2016, Pages: 283–293, A. C. Cheung, L. Lapointe-Shaw, M. Kowgier, J. Meza-Cardona, G. M. Hirschfield, H. L. A. Janssen and J. J. Feld

    Version of Record online : 12 NOV 2015, DOI: 10.1111/apt.13465

  13. Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis

    Hepatology Research

    Volume 45, Issue 8, August 2015, Pages: 846–855, Minoru Nakamura, Hisayoshi Kondo, Atsushi Tanaka, Atsumasa Komori, Masahiro Ito, Kazuhide Yamamoto, Hiromasa Ohira, Mikio Zeniya, Etsuko Hashimoto, Masao Honda, Shuichi Kaneko, Yoshiyuki Ueno, Kentaro Kikuchi, Shinji Shimoda, Kenichi Harada, Kuniaki Arai, Yasuhiro Miyake, Masanori Abe, Makiko Taniai, Toshiji Saibara, Shotaro Sakisaka, Hajime Takikawa, Morikazu Onji, Hirohito Tsubouchi, Yasuni Nakanuma and Hiromi Ishibashi

    Version of Record online : 11 DEC 2014, DOI: 10.1111/hepr.12423

  14. Evidence for the association between IgG-antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis

    Journal of Gastroenterology and Hepatology

    Volume 32, Issue 3, March 2017, Pages: 659–666, Libo Tang, Ruihua Zhong, Xuanqiu He, Weibin Wang, Jinhong Liu, Youfu Zhu, Yongyin Li and Jinlin Hou

    Version of Record online : 20 MAR 2017, DOI: 10.1111/jgh.13534

  15. You have free access to this content
    Management of cholestatic disease in 2017

    Liver International

    Volume 37, Issue S1, January 2017, Pages: 123–129, Elsemieke de Vries and Ulrich Beuers

    Version of Record online : 3 JAN 2017, DOI: 10.1111/liv.13306

  16. Biochemical response to ursodeoxycholic acid predicts long-term outcome in Japanese patients with primary biliary cirrhosis

    Hepatology Research

    Volume 41, Issue 4, April 2011, Pages: 310–317, Nobuaki Azemoto, Teru Kumagi, Masanori Abe, Ichiro Konishi, Bunzo Matsuura, Yoichi Hiasa and Morikazu Onji

    Version of Record online : 22 MAR 2011, DOI: 10.1111/j.1872-034X.2011.00782.x

  17. You have free access to this content
    Efficacy of fenofibrate in Chinese patients with primary biliary cirrhosis partially responding to ursodeoxycholic acid therapy

    Journal of Digestive Diseases

    Volume 13, Issue 4, April 2012, Pages: 219–224, Xiao Feng HAN, Qi Xia WANG, Yuan LIU, Zheng Rui YOU, Zhao Lian BIAN, De Kai QIU and Xiong MA

    Version of Record online : 21 MAR 2012, DOI: 10.1111/j.1751-2980.2012.00574.x

  18. You have free access to this content
    Poster Session I (Abstracts 259 – 729)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 136–361,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28797

  19. You have free access to this content
    Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: Results of a 14-year cohort study

    Hepatology

    Volume 58, Issue 1, July 2013, Pages: 264–272, Li-Na Zhang, Tian-Yan Shi, Xu-Hua Shi, Li Wang, Yun-Jiao Yang, Bin Liu, Li-Xia Gao, Zong-Wen Shuai, Fang Kong, Hua Chen, Wei Han, Shao-Mei Han, Yun-Yun Fei, Quan-Cai Cui, Qian Wang, Min Shen, Dong Xu, Wen-Jie Zheng, Yong-Zhe Li, Wen Zhang, Xuan Zhang and Feng-Chun Zhang

    Version of Record online : 27 MAY 2013, DOI: 10.1002/hep.26322

  20. You have free access to this content
    Treatment of primary biliary cirrhosis: Is there more to offer than ursodeoxycholic acid?

    Clinical Liver Disease

    Volume 3, Issue 2, February 2014, Pages: 29–33, Albert Parés

    Version of Record online : 5 MAR 2014, DOI: 10.1002/cld.311